Is the dose-related reduction in succinylcholine-induced myalgia due to cointervention?
Kettler
Robert E
RE
D005207:Fasciculation / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D009467:Neuromuscular Depolarizing Agents / Q000008:administration & dosage / Q000009:adverse effects; D013390:Succinylcholine / Q000008:administration & dosage* / Q000009:adverse effects
D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine